Index -
P/E -
EPS (ttm) -0.94
Insider Own 7.05%
Shs Outstand 110.27M
Perf Week 29.63%
Market Cap 7.28B
Forward P/E -
EPS next Y -1.48
Insider Trans -9.41%
Shs Float 102.50M
Perf Month 39.23%
Income -96.75M
PEG -
EPS next Q -0.24
Inst Own 72.99%
Short Float 14.73%
Perf Quarter -4.18%
Sales 0.00M
P/S -
EPS this Y -7.57%
Inst Trans -0.29%
Short Ratio 4.00
Perf Half Y 206.74%
Book/sh 8.31
P/B 7.94
EPS next Y -50.87%
ROA -14.36%
Short Interest 15.10M
Perf Year 362.04%
Cash/sh 8.55
P/C 7.72
EPS next 5Y 40.00%
ROE -14.80%
52W Range 8.28 - 99.41
Perf YTD 254.54%
Dividend Est. -
P/FCF -
EPS past 5Y -18.89%
ROI -10.50%
52W High -33.63%
Beta 1.00
Dividend TTM -
Quick Ratio 37.69
Sales past 5Y 0.00%
Gross Margin -
52W Low 696.86%
ATR (14) 4.82
Dividend Ex-Date -
Current Ratio 37.69
EPS Y/Y TTM -3.58%
Oper. Margin 0.00%
RSI (14) 65.57
Volatility 9.37% 7.53%
Employees 27
Debt/Eq 0.00
Sales Y/Y TTM -
Profit Margin -
Recom 1.00
Target Price 113.55
Option/Short Yes / Yes
LT Debt/Eq 0.00
EPS Q/Q -3.81%
Payout -
Rel Volume 2.42
Prev Close 64.68
Sales Surprise -
EPS Surprise 23.84%
Sales Q/Q -
Earnings Jul 24 AMC
Avg Volume 3.78M
Price 65.98
SMA20 22.54%
SMA50 16.04%
SMA200 53.70%
Trades
Volume 9,158,727
Change 2.01%
Date
Action
Analyst
Rating Change
Price Target Change
Jun-27-24 Initiated
Morgan Stanley
Overweight
$105
May-16-24 Upgrade
Raymond James
Outperform → Strong Buy
$115 → $116
Mar-26-24 Reiterated
Oppenheimer
Outperform
$116 → $138
Mar-07-24 Initiated
Jefferies
Buy
$110
Feb-28-24 Reiterated
Oppenheimer
Outperform
$46 → $116
May-31-23 Resumed
ROTH MKM
Buy
$32
Mar-28-23 Reiterated
Maxim Group
Buy
$15 → $25
Mar-17-23 Initiated
Stifel
Buy
$22
Jul-29-21 Resumed
BTIG Research
Buy
$20
May-25-21 Downgrade
Raymond James
Strong Buy → Outperform
$27 → $12
Jun-05-20 Initiated
BMO Capital Markets
Outperform
$14
May-05-20 Initiated
Chardan Capital Markets
Buy
$15
May-01-20 Initiated
BTIG Research
Buy
$9
Jul-16-19 Initiated
Oppenheimer
Outperform
$12
Jun-25-19 Initiated
Stifel
Buy
Mar-29-19 Upgrade
SVB Leerink
Mkt Perform → Outperform
$10 → $21
Mar-14-19 Reiterated
Maxim Group
Buy
$28 → $20
Feb-22-19 Initiated
SVB Leerink
Mkt Perform
Dec-12-18 Initiated
B. Riley FBR
Buy
$16
Nov-19-18 Upgrade
Raymond James
Outperform → Strong Buy
Show Previous Ratings
Today 04:07PM
01:55PM
11:03AM
10:38AM
07:37AM
07:06PM
Loading…
Jul-25-24 07:06PM
04:11PM
(Investor's Business Daily)
01:14PM
12:13PM
12:03PM
12:01PM
12:01PM
11:24AM
11:03AM
09:44AM
09:29AM
Loading…
09:29AM
06:28AM
05:00AM
Jul-24-24 04:05PM
Jul-22-24 09:20AM
Jul-21-24 06:59AM
Jul-20-24 06:00AM
Jul-19-24 05:45PM
09:51AM
05:50AM
Jul-18-24 05:50PM
07:00AM
Jul-17-24 04:12PM
(Investor's Business Daily) -12.56%
04:05PM
10:47AM
08:45AM
Loading…
08:45AM
(Investor's Business Daily)
07:25AM
Jul-12-24 06:08AM
Jul-11-24 05:42AM
Jul-10-24 06:41AM
Jul-08-24 12:32PM
Jul-06-24 08:00AM
Jul-03-24 11:11AM
Jul-02-24 11:06AM
Jul-01-24 08:15AM
07:45AM
Jun-30-24 06:53AM
Jun-29-24 08:50PM
08:48PM
08:45PM
08:43PM
08:40PM
08:37PM
08:35PM
08:32PM
08:28PM
08:26PM
06:30PM
Jun-28-24 10:09AM
06:00AM
05:50AM
Jun-27-24 04:09PM
Jun-26-24 05:50PM
07:45AM
Jun-24-24 07:33AM
Jun-20-24 05:50PM
Jun-18-24 08:34AM
07:50AM
Jun-17-24 05:50AM
Jun-15-24 09:31AM
07:45AM
Jun-14-24 05:50AM
Jun-13-24 05:45PM
09:30AM
Jun-12-24 10:00AM
Jun-11-24 06:52AM
Jun-10-24 09:45AM
Jun-09-24 08:45AM
Jun-08-24 07:40AM
Jun-07-24 05:45PM
02:52AM
Jun-06-24 05:23PM
07:45AM
Jun-05-24 10:28AM
09:42AM
Jun-04-24 04:17PM
(Investor's Business Daily) -9.70%
01:36PM
08:00AM
07:46AM
07:05AM
06:00AM
Jun-03-24 10:15AM
09:00AM
May-31-24 05:45PM
06:00AM
06:00AM
05:33AM
May-30-24 04:03PM
May-29-24 06:30AM
May-28-24 09:30AM
May-27-24 06:58PM
06:13PM
May-26-24 08:31AM
May-25-24 12:00PM
08:15AM
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
ZANTE GREG Chief Financial Officer May 03 '24 Option Exercise 4.86 34,249 166,285 241,610 May 03 08:51 PM ZANTE GREG Chief Financial Officer May 03 '24 Sale 74.69 66,756 4,986,008 174,854 May 03 08:51 PM Mancini Marianna Chief Operating Officer May 01 '24 Option Exercise 6.18 281,425 1,740,575 629,933 May 02 09:27 PM Mancini Marianna Chief Operating Officer May 01 '24 Sale 78.66 281,425 22,136,474 348,508 May 02 09:27 PM Lian Brian President & CEO Feb 09 '24 Sale 29.90 45,000 1,345,500 2,139,882 Feb 09 08:59 PM Lian Brian President & CEO Feb 08 '24 Option Exercise 3.76 189,079 711,367 2,404,882 Feb 08 07:40 PM Rouan Sarah Kathryn Director Feb 08 '24 Option Exercise 8.32 25,000 208,000 25,000 Feb 08 07:38 PM Lian Brian President & CEO Feb 08 '24 Sale 26.87 269,079 7,230,784 2,184,882 Feb 08 07:40 PM Rouan Sarah Kathryn Director Feb 08 '24 Sale 28.05 25,000 701,250 0 Feb 08 07:38 PM Lian Brian President & CEO Jan 31 '24 Option Exercise 1.23 85,000 104,550 2,349,882 Jan 31 08:39 PM Lian Brian President & CEO Jan 31 '24 Sale 24.71 85,000 2,100,750 2,264,882 Jan 31 08:39 PM Lian Brian President & CEO Jan 30 '24 Option Exercise 1.23 35,000 43,050 2,299,882 Jan 30 09:05 PM Lian Brian President & CEO Jan 30 '24 Sale 23.95 35,000 838,250 2,264,882 Jan 30 09:05 PM Rouan Sarah Kathryn Director Jan 19 '24 Option Exercise 8.32 30,000 249,600 30,000 Jan 19 08:35 PM Rouan Sarah Kathryn Director Jan 19 '24 Sale 23.05 30,000 691,500 0 Jan 19 08:35 PM ZANTE GREG Chief Financial Officer Jan 04 '24 Sale 17.90 15,000 268,500 180,730 Jan 04 09:35 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite